Research and Markets: 2013 Report 'Oncology Deals and Alliances' is a Vital Report for Those in the Cancer Field
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xldd9t/oncology_deals) has announced the addition of the "Oncology Deals and Alliances of 2013" report to their offering.
The Oncology Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.
The initial chapters of this report provide an orientation of 2013's dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication.
Chapter 2 provides a review of the leading deals during 2013. Deals are listed by headline value, signed by bigpharma and bigbiotech, and most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 3 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of 2013 deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2013.
The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma partnering and dealmaking during 2013.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2013.
- Baxter International
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Dainippon Sumitomo
- Eli Lilly
- Endo Pharmaceuticals
- Forest Laboratories
- Johnson & Johnson
- Kyowa Hakko Kirin
- Mitsubishi Tanabe
- Novo Nordisk
- Warner Chilcott
For more information visit http://www.researchandmarkets.com/research/xldd9t/oncology_deals
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.